Amneal Pharmaceuticals, Inc.AMRXNASDAQ
Loading
Year-over-year research & development expense growth
Latest
-2.38%
↓ 157% vs avg
Percentile
P36
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
4.17%
Historical baseline
| Period | Value |
|---|---|
| 2025 | -2.38% |
| 2024 | -2.07% |
| 2023 | -6.67% |
| 2022 | -0.43% |
| 2021 | 9.96% |
| 2020 | -5.78% |
| 2019 | -3.88% |
| 2018 | 9.65% |
| 2017 | -6.26% |
| 2016 | 49.59% |